Oxurion further improves THR-149 patent position

Oxurion NV, a biopharmaceutical company, announced that it has prevailed in final proceedings before the European Patent Office in opposition to Dyax Corp.’s European patents 1 854 477 and 2 374 472. The European Board of Appeal announced its...

Apollo Cancer Centre performs endoscopic transcanal excision of facial nerve schwannoma

Oncologists at Apollo Cancer Centre, Bangalore have successfully performed endoscopic trans canal excision of facial nerve schwannoma on a 35-year-old patient who was suffering from right-sided facial weakness for the last two years....

Eli Lilly introduces medication for early stage breast cancer

Drug firm Eli Lilly and Company (India) said it has launched a product to treat early stage breast cancer after receiving approval from the Drug Controller General of India. The company has introduced Ramiven in strengths of 50 mg, 100 mg, 150 mg...

Indian pharma exports jump by 138 per cent in post pandemic era

India’s pharma exports have increased 138 per cent in April-October 2022-23 compared to the same period of 2013-14 when the country became the pharmacy for the world...

Okyo Pharma files IND application with US FDA for development of OK-101 to treat dry eye disease

Okyo Pharma Limited, an ophthalmology-focused bio-pharmaceutical company, announced that it filed an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) for the development of OK-101 to treat dry eye disease...

Top Three Trends in RNA Therapeutics

Novel innovations are now actively hitting the market with an expectation to alter the course of drug manufacturing. In this article, we have listed the top trends in the RNA therapeutic industry:

MSD to acquire Imago BioSciences for $1.35B

Merck, known as MSD outside the United States and Canada, and Imago BioSciences, Inc. (Imago) announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Imago for $36.00 per share in...

Alembic Pharmaceuticals gets final USFDA approval for Nifedipine

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Procardia XL extended-release tablets, 30 mg, 60 mg and 90 mg, of Pfizer Inc...

Viz.ai announces positive new data from large aortic dissection AI real-world study

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, announced new data from a large aortic dissection artificial intelligence real-world study that supports the use of its artificial intelligence technology for...

Strides Pharma arms gets USFDA approval for potassium-deficiency drug

Strides Pharma Science Ltd on Friday said its Singapore-based arm has received approval from the US health regulator for generic potassium chloride oral solution, used to treat or prevent low amounts of potassium in the blood. The approval granted...

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.